News
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.
23d
GlobalData on MSNAstraZeneca and Alteogen agree on ALT-B4 platform techAlteogen will earn royalties on the sales of products commercialised under this agreement. AstraZeneca oncology chief ...
Additionally, Alteogen will receive royalties on the sales of the commercialized products. On Monday, the European Union approved AstraZeneca’s Imfinzi (durvalumab) as monotherapy for adults ...
UK-based global pharma company AstraZeneca and US consumer products company Honeywell have announced a partnership to build a new "next generation" inhaler with a propellant that reduces Global ...
They include Johnson & Johnson, Eli Lilly, AstraZeneca and GSK. But many firms still make the active ingredients for these ...
In a separate press release, AstraZeneca announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has adopted a positive opinion recommending the ...
AstraZeneca has revealed it has expanded membership ... representation of the company’s scientific expertise, key products and key markets. The changes include the creation of: • Three senior ...
AstraZeneca AZN-6.74%decrease; red down pointing triangle plans to invest $2.5 billion in China over five years to build a research-and-development center and strike deals with local biotechnology ...
Learn more about whether AstraZeneca PLC or Jazz Pharmaceuticals plc is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
AstraZeneca investing $2.5 billion in China as drugmaker seeks to recover from scandals AstraZeneca said on Friday it will spend $2.5 billion on a research and development hub in Beijing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results